Oxidative damage and schizophrenia: An overview of the evidence and its therapeutic implications

CNS Drugs

Volumn 15, Issue 4, 2001, Pages 287-310

  Yao, Jeffrey K ^a,b   Reddy, Ravinder D ^b   Van Kammen, Daniel P ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Robert Wood Tohnson PRI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; BILIRUBIN; CYTOCHROME C OXIDASE; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID;

ANTIOXIDANT ACTIVITY; CIGARETTE SMOKING; CONTROLLED STUDY; FATTY ACID SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID PEROXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

EID: 0035054355     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200115040-00004     Document Type: Review

References (2)

1. Lieberman JA, Koreen AR. Neurochemistry and neuroendocrinology of schizophrenia: a selective review. Schizophr Bull 1993; 19: 371-429
2. Horrobin DF, Glen AIM, Hudson CJ. Posssible relevance of phosplolipid abnormalities and genetic interactions in psychiatric disorders; the relationship between dyslexia and schizophrenia. Med Hypotheses 1995; 45: 605-13